Study Results from MetroHealth System in the Area of Proinsulin Reported (Best Practices and Rationale for Expanding Medicaid Access To Continuous Glucose Monitoring): Peptide Proteins – Proinsulin

2024 DEC 09 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Fresh data on Peptide Proteins - Proinsulin are presented in a new report. According to news reporting originating in Cleveland, Ohio, by NewsRx journalists, research stated, “Numerous studies have demonstrated that use of continuous glucose monitoring (CGM) significantly improves overall glycemic control and reduces the frequency and severity of hypoglycemic events in individuals treated with intensive insulin, nonintensive insulin, and noninsulin therapies, with reductions in both all-cause and diabetes-related health care resource utilization and lower costs.”

Financial support for this research came from Abbott Laboratories.

The news reporters obtained a quote from the research from MetroHealth System, “However, implementation of CGM including prescribing and assessment of the ambulatory glucose profile to make clinical decisions in primary care settings is low. A recent pilot program was initiated at MetroHealth System (Cleveland, Ohio) to implement a CGM integration program for primary care offices throughout the system.”

According to the news reporters, the research concluded: “Based on the experience and successes from this health system as well as current literature, rationale will be discussed to support the expansion of CGM to individuals enrolled in all Medicaid programs.”

This research has been peer-reviewed.

For more information on this research see: Best Practices and Rationale for Expanding Medicaid Access To Continuous Glucose Monitoring. Journal of Managed Care & Specialty Pharmacy, 2024;30(10). Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

Our news correspondents report that additional information may be obtained by contacting Cynthia A. King, MetroHealth System, MetroHlth Pharm Dept, Cleveland, OH 44109, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)